1. Centers for Disease Control and Prevention.
Elimination of rubella and congenital rubella syndrome—United
States, 1969-2004. MMWR Morb Mortal Wkly Rep. 2005;54:279-282.
2. Reef SE, Cochi SL. The evidence for the elimination of rubella
and congenital rubella syndrome in the United States: a public health
achievement. Clin Infect Dis. 2006;43(suppl 3):S123-125.
3. Weller TH, Neva FA. Propagation in tissue culture of cytopathic agents
from patients with rubella-like illnesses. Pros Soc Exp
Biol Med. 1962;111:215-225.
4. WHO. Update of standard nomenclature for wild-type rubella viruses,
2007. Wkly Epidemiol Rec. 2007;(24):216-222.
5. Bloom S, Smith P, Stanwyck C, Stokley S. Has the United States population
been adequately vaccinated to achieve rubella elimination? Clin
Infect Dis. 2006;43(suppl. 3):S141-145.
6. Icenogle JP, Frey TK, Abernathy E, Reef SE, Schnurr D, Stewart
JA. Genetic analysis of rubella viruses found in the United States
between 1966 and 2004: evidence that indigenous rubella viruses
have been eliminated. Clin Infect Dis. 2006;43(suppl
3):S133-S140.
7. Reef SE, Redd SB, Abernathy E, Zimmerman L, Icenogle JP. The
epidemiological profile of rubella and congenital rubella syndrome
in the United States, 1998-2004: the evidence for absence of endemic
transmission. Clin Infect Dis. 2006;43(suppl 3):S126-S132.
8. Schluter WW, Reef SE, Redd SC, Dykewicz CA. Changing epidemiology
of congenital rubella syndrome in the United States. J Infect
Dis. 1998;178(3):636-641.
9. Plotkin SA, Katz M, Cordero JF. The eradication of rubella. JAMA. 1999;281(6):561-562.
10. Reef SE, Frey TK, Theall K, et al. The changing epidemiology
of rubella in the 1990s: on the verge of elimination and new challenges
for control and prevention. JAMA. 2002;287(4):464-472.
11. Hyde TB, Kruszon-Moran D, McQuillan GM, Cossen C, Forghani
B, Reef SE. Rubella immunity levels in the United States population:
has the threshold of viral elimination been reached? Clin
Infect Dis. 2006;43(suppl 3):S146-S150.
12. Atreya CD, Mohan KV, Kulkarni S. Rubella virus and birth defects:
molecular insights into the viral teratogenesis at the cellular level. Birth
Defects Res A Clin Mol Teratol. 2004;70(7):431-437.
13. Peltola H, Leinikki P. Rubella gene sequencing as a clinician's
tool. Lancet. 1998;352(9143):1799-1800.
14. Best JM, Castillo-Solorzano C, Spika JS, et al. Reducing
the global burden of congenital rubella syndrome: report of the
World Health Organization Steering Committee on research related
to measles and rubella vaccines and vaccination, June 2004. J
Infect Dis. 2005;192(11):1890-1897.
15. Banatvala JE, Brown DW. Rubella. Lancet. 2004;363(9415):1127-1137.
16. Bosma TJ, Etherington J, O'Shea S, et al. Rubella virus
and chronic joint disease: is there an association? J Clin
Microbiol. 1998;36(12):3524-3526.
17. Pool V, Chen R, Rhodes P. Indications for measles-mumps-rubella
vaccination in a child with prior thrombocytopenia purpura. Pediatr
Infect Dis J. 1997;16(4):423-424.
18. Davidkin I, Valle M, Peltola H, et al. Etiology of measles-
and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J
Infect Dis. 1998;178(6):1567-1570.
19. Litwin CM HH. Serologic and DNA-based testing for congenital and
perinatal infections.
Pediatr Infect Dis J. 1997;16:1166-1175.
[PubMed: 9427464]
20. Cooray S, Warrener L, Jin L. Improved RT-PCR for diagnosis and
epidemiological surveillance of rubella. J Clin Virol. 2006;35(1):73-80.
21. Centers for Disease Control and Prevention. Recommendations
from an ad hoc meeting of the WHO measles and rubella laboratory
network (LabNet) on use of alternative diagnostic samples for measles
and rubella surveillance. MMWR Morb Mortal Wkly Rep. 2008;57:657-660.
22. Dwyer DE, Robertson PW, Field PR. Broadsheet: Clinical and laboratory
features of rubella. Pathology. 2001;33(3):322-328.
23. Dykewicz CA, Kruszon-Moran D, McQuillan GM, et al. Rubella
seropositivity in the United States, 1988–1994. Clin
Infect Dis. 2001;33(8): 1279-1286.
24. D'Angio CT, Boohene PA, Mowrer A, et al. Measles-mumps-rubella
and varicella vaccine responses in extremely preterm infants. Pediatrics. 2007;119(3):e574-579.
25. Robinson JL, Lee BE, Preiksaitis JK, Plitt S, Tipples GA.
Prevention of congenital rubella syndrome—what makes sense
in 2006?
Epidemiol Rev. 2006;28:81-87.
[PubMed: 16775038]
26. Plotkin SA. The history of rubella and rubella vaccination
leading to elimination. Clin Infect Dis. 2006;43(suppl
3):S164-168.
27. Hofmann J, Kortung M, Pustowoit B, Faber R, Piskazeck U,
Liebert UG. Persistent fetal rubella vaccine virus infection following inadvertent
vaccination during early pregnancy. J Med Virol. 2000;61(1):155-158.
28. Gregg NM. Congenital cataract following German measles in the
mother. Trans Ophthal Soc Aust. 1941;3:35-46.
29. Lee JY, Bowden DS. Rubella virus replication and links to
teratogenicity. Clin Microbiol Rev. 2000;13(4):571-587.
30. Sever JL, Nelson KB, Gilkeson MR. Rubella epidemic, 1964: effect
on 6,000 pregnancies. Am J Dis Child. 1965;110(4):395-407.
31. South MA, Sever JL. Teratogen update: the congenital rubella
syndrome. Teratology. 1985;31(2):2 97-307.
32. Best JM, Banatvala JE: Rubella. In: Zuckerman AJ, Banatvala JE,
Pattison JR, eds. Principles and Practice of Clinical Virology.
New York: Wiley; 2000:387-418.
33. Morgan-Capner P, Miller E, Vurdien JE, Ramsey ME. Outcome
of pregnancy after maternal reinfection with rubella. CDR
(Lond Engl Rev). 1991;1:R57-59.
34. Robinson JLM, Vaudry WL. Congenital rubella after anticipated
maternal immunity: two cases and a review of the literature.
Pediatr
Infect Dis J. 1994;13:812-815.
[PubMed: 7808852]
35. Tipples GA, Hamkar R, Mohktari-Azad T, et al. Evaluation
of rubella IgM enzyme immunoassays. J Clin Virol. 2004;30(3):233-238.
36. Mubareka S, Richards H, Gray M, Tipples GA. Evaluation of
commercial rubella immunoglobulin G avidity assays. J Clin
Microbiol. 2007;45(1):2 31-233.
37. WHO. Reducing global disease burden of measles and rubella:
Report of the WHO Steering Committee on research related to measles
and rubella vaccines and vaccination, 2005. Vaccine. 2007;25:1-9.
38. Menser MA, Dods L, Harley JD. A twenty-five-year follow-up of
congenital rubella. Lancet. 1967;2(7530):1347-1350.
39. McIntosh ED, Menser MA. A fifty-year follow-up of congenital
rubella. Lancet. 1992;340(8816):414-415.
40. Forrest JM, Turnbull FM, Sholler GF, et al. Gregg's congenital
rubella patients 60 years later. Med J Aust. 2002;177(11-12):664-667.
41. Noticeboard. Congenital rubella—50 years on. Lancet. 1991;337:668.